Skip to main content

Amy Kao, PhD

Dr. Amy Kao joined TVM Capital in April 2023.

Prior to TVM, Amy focused on building and funding healthtech opportunities at Oxford Science Enterprises, the largest university-affiliated investment company in the world. Amy was previously a management consultant at EY Global, advising transaction strategies for health care & life science corporations. She has hands-on experience in venture ideation from Merck KGaA’s Innovation Centre and company creation from her role as Chief of Staff at a Parkinson’s and Dementia digital health start-up.

Her academic work in the gut-brain axis has been published in Nature’s Translational Psychiatry and other high-impact journals. Amy holds a DPhil in Neuroscience from the University of Oxford.